Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.67B.
ENTERPRISE VALUE (EV)
$2.67B
Alamar Biosciences, Inc.
Market Cap
$2.69B
Enterprise Value (EV)
$2.67B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.69B | $2.67B |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | $5.08B |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | $4.09B |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | $2.79B |
| AtriCure, Inc. (ATRC)vs › | $2.85B | $2.75B |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | $3.26B |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | $2.02B |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | $2.24B |
| Disc Medicine, Inc. (IRON)vs › | $2.45B | $2.41B |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | $2.23B |
Market Cap
$2.69B
Total Debt
$9.81M
Cash
$30.00M
Enterprise Value
$2.67B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
